|
1
|
Kamisawa T, Wood LD, Itoi T and Takaori K:
Pancreatic cancer. Lancet. 388:73–85. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Le A, Rajeshkumar NV, Maitra A and Dang
CV: Conceptual framework for cutting the pancreatic cancer fuel
supply. Clin Cancer Res. 18:4285–4290. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Sousa CM and Kimmelman AC: The complex
landscape of pancreatic cancer metabolism. Carcinogenesis.
35:1441–1450. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Cantor JR and Sabatini DM: Cancer cell
metabolism: One hallmark, many faces. Cancer Discov. 2:881–898.
2012. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Ying H, Kimmelman AC, Lyssiotis CA, Hua S,
Chu GC, Fletcher-Sananikone E, Locasale JW, Son J, Zhang H, Coloff
JL, et al: Oncogenic Kras maintains pancreatic tumors through
regulation of anabolic glucose metabolism. Cell. 149:656–670. 2012.
View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Meijer TW, Kaanders JH, Span PN and
Bussink J: Targeting hypoxia, HIF-1, and tumor glucose metabolism
to improve radiotherapy efficacy. Clin Cancer Res. 18:5585–5594.
2012. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Li B and Simon MC: Molecular Pathways:
Targeting MYC-induced metabolic reprogramming and oncogenic stress
in cancer. Clin Cancer Res. 19:5835–5841. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Miller DM, Thomas SD, Islam A, Muench D
and Sedoris K: c-Myc and cancer metabolism. Clin Cancer Res.
18:5546–5553. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Smith SC and Theodorescu D: Learning
therapeutic lessons from metastasis suppressor proteins. Nat Rev
Cancer. 9:253–264. 2009. View
Article : Google Scholar : PubMed/NCBI
|
|
10
|
Angst E, Dawson DW, Stroka D, Gloor B,
Park J, Candinas D, Reber HA, Hines OJ and Eibl G: N-myc downstream
regulated gene-1 expression correlates with reduced pancreatic
cancer growth and increased apoptosis in vitro and in vivo.
Surgery. 149:614–624. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Liu W, Yue F, Zheng M, Merlot A, Bae DH,
Huang M, Lane D, Jansson P, Lui GY, Richardson V, et al: The
proto-oncogene c-Src and its downstream signaling pathways are
inhibited by the metastasis suppressor, NDRG1. Oncotarget.
6:8851–8874. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Jain S, Wang X, Chang CC, Ibarra-Drendall
C, Wang H, Zhang Q, Brady SW, Li P, Zhao H, Dobbs J, et al: Src
inhibition blocks c-Myc translation and glucose metabolism to
prevent the development of breast cancer. Cancer Res. 75:4863–4875.
2015. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Ji S, Qin Y, Liang C, Huang R, Shi S, Liu
J, Jin K, Liang D, Xu W, Zhang B, et al: FBW7 (F-box and WD repeat
domain-containing 7) negatively regulates glucose metabolism by
targeting the c-Myc/TXNIP (thioredoxin-binding protein) axis in
pancreatic cancer. Clin Cancer Res. 22:3950–3960. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Emerling BM, Weinberg F, Liu JL, Mak TW
and Chandel NS: PTEN regulates p300-dependent hypoxia-inducible
factor 1 transcriptional activity through Forkhead transcription
factor 3a (FOXO3a). Proc Natl Acad Sci USA. 105:2622–2627. 2008.
View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Kennedy AL, Adams PD and Morton JP: Ras,
PI3K/Akt and senescence: Paradoxes provide clues for pancreatic
cancer therapy. Small GTPases. 2:264–267. 2011. View Article : Google Scholar
|
|
16
|
Harada H, Itasaka S, Kizaka-Kondoh S,
Shibuya K, Morinibu A, Shinomiya K and Hiraoka M: The Akt/mTOR
pathway assures the synthesis of HIF-1alpha protein in a glucose-
and reoxygenation-dependent manner in irradiated tumors. J Biol
Chem. 284:5332–5342. 2009. View Article : Google Scholar
|
|
17
|
Denko NC: Hypoxia, HIF1 and glucose
metabolism in the solid tumour. Nat Rev Cancer. 8:705–713. 2008.
View Article : Google Scholar
|
|
18
|
Kurdistani SK, Arizti P, Reimer CL, Sugrue
MM, Aaronson SA and Lee SW: Inhibition of tumor cell growth by
RTP/rit42 and its responsiveness to p53 and DNA damage. Cancer Res.
58:4439–4444. 1998.PubMed/NCBI
|
|
19
|
Guan RJ, Ford HL, Fu Y, Li Y, Shaw LM and
Pardee AB: Drg-1 as a differentiation-related, putative metastatic
suppressor gene in human colon cancer. Cancer Res. 60:749–755.
2000.PubMed/NCBI
|
|
20
|
Bandyopadhyay S, Pai SK, Gross SC, Hirota
S, Hosobe S, Miura K, Saito K, Commes T, Hayashi S, Watabe M, et
al: The Drg-1 gene suppresses tumor metastasis in prostate cancer.
Cancer Res. 63:1731–1736. 2003.PubMed/NCBI
|
|
21
|
Liu W, Xing F, Iiizumi-Gairani M, Okuda H,
Watabe M, Pai SK, Pandey PR, Hirota S, Kobayashi A, Mo YY, et al:
N-myc downstream regulated gene 1 modulates Wnt-β-catenin
signalling and pleiotropically suppresses metastasis. EMBO Mol Med.
4:93–108. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Mann KM, Ying H, Juan J, Jenkins NA and
Copeland NG: KRAS-related proteins in pancreatic cancer. Pharmacol
Ther. 168:29–42. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Logsdon CD and Lu W: The significance of
Ras activity in pancreatic cancer initiation. Int J Biol Sci.
12:338–346. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Jones RG and Thompson CB: Tumor
suppressors and cell metabolism: A recipe for cancer growth. Genes
Dev. 23:537–548. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Yun J, Rago C, Cheong I, Pagliarini R,
Angenendt P, Rajagopalan H, Schmidt K, Willson JK, Markowitz S,
Zhou S, et al: Glucose deprivation contributes to the development
of KRAS pathway mutations in tumor cells. Science. 325:1555–1559.
2009. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Guo JY, Chen HY, Mathew R, Fan J,
Strohecker AM, Karsli-Uzunbas G, Kamphorst JJ, Chen G, Lemons JM,
Karantza V, et al: Activated Ras requires autophagy to maintain
oxidative metabolism and tumorigenesis. Genes Dev. 25:460–470.
2011. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Hosoi F, Izumi H, Kawahara A, Murakami Y,
Kinoshita H, Kage M, Nishio K, Kohno K, Kuwano M and Ono M: N-myc
downstream regulated gene 1/Cap43 suppresses tumor growth and
angiogenesis of pancreatic cancer through attenuation of inhibitor
of kappaB kinase beta expression. Cancer Res. 69:4983–4991. 2009.
View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Guillaumond F, Leca J, Olivares O, Lavaut
MN, Vidal N, Berthezène P, Dusetti NJ, Loncle C, Calvo E, Turrini
O, et al: Strengthened glycolysis under hypoxia supports tumor
symbiosis and hexosamine biosynthesis in pancreatic adenocarcinoma.
Proc Natl Acad Sci USA. 110:3919–3924. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Sun HC, Qiu ZJ, Liu J, Sun J, Jiang T,
Huang KJ, Yao M and Huang C: Expression of hypoxia-inducible
factor-1α and associated proteins in pancreatic ductal
adenocarcinoma and their impact on prognosis. Int J Oncol.
30:1359–1367. 2007.PubMed/NCBI
|
|
30
|
Maruyama Y, Ono M, Kawahara A, Yokoyama T,
Basaki Y, Kage M, Aoyagi S, Kinoshita H and Kuwano M: Tumor growth
suppression in pancreatic cancer by a putative metastasis
suppressor gene Cap43/NDRG1/Drg-1 through modulation of
angiogenesis. Cancer Res. 66:6233–6242. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Iyer NV, Kotch LE, Agani F, Leung SW,
Laughner E, Wenger RH, Gassmann M, Gearhart JD, Lawler AM, Yu AY,
et al: Cellular and developmental control of O2 homeostasis by
hypoxia-inducible factor 1 alpha. Genes Dev. 12:149–162. 1998.
View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Chaika NV, Gebregiworgis T, Lewallen ME,
Purohit V, Radhakrishnan P, Liu X, Zhang B, Mehla K, Brown RB,
Caffrey T, et al: MUC1 mucin stabilizes and activates
hypoxia-inducible factor 1 alpha to regulate metabolism in
pancreatic cancer. Proc Natl Acad Sci USA. 109:13787–13792. 2012.
View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Chen C, Pore N, Behrooz A, Ismail-Beigi F
and Maity A: Regulation of glut1 mRNA by hypoxia-inducible
factor-1. Interaction between H-ras and hypoxia. J Biol Chem.
276:9519–9525. 2001. View Article : Google Scholar
|
|
34
|
Firth JD, Ebert BL and Ratcliffe PJ:
Hypoxic regulation of lactate dehydrogenase A. Interaction between
hypoxia-inducible factor 1 and cAMP response elements. J Biol Chem.
270:21021–21027. 1995. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Mathupala SP, Rempel A and Pedersen PL:
Glucose catabolism in cancer cells: Identification and
characterization of a marked activation response of the type II
hexokinase gene to hypoxic conditions. J Biol Chem.
276:43407–43412. 2001. View Article : Google Scholar : PubMed/NCBI
|
